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Pyridoxamine-pyruvate aminotransferase (PPAT; EC 2.6.1.30)
is a pyridoxal 5-phosphate-independent aminotransferase
and catalyzes reversible transamination between pyridoxam-
ine and pyruvate to form pyridoxal and L-alanine. The crystal
structure of PPAT from Mesorhizobium loti has been solved
in space group P43212 and was refined to an R factor of 15.6%
(Rfree 20.6%) at 2.0 A˚ resolution. In addition, the structures of
PPAT in complexes with pyridoxamine, pyridoxal, and pyri-
doxyl-L-alanine have been refined to R factors of 15.6, 15.4, and
14.5% (Rfree 18.6, 18.1, and 18.4%) at 1.7, 1.7, and 2.0 A˚ reso-
lution, respectively. PPAT is a homotetramer and each subunit
is composed of a large N-terminal domain, consisting of seven
-sheets and eight -helices, and a smaller C-terminal domain,
consisting of three -sheets and four -helices. The substrate
pyridoxal is bound through an aldimine linkage to Lys-197 in
the active site. The-carboxylate group of the substrate amino/
keto acid is hydrogen-bonded to Arg-336 and Arg-345. The
structures revealed that the bulky side chain of Glu-68 inter-
fered with the binding of the phosphate moiety of pyridoxal
5-phosphate and made PPAT specific to pyridoxal. The reac-
tion mechanism of the enzyme is discussed based on the struc-
tures and kinetics results.
Pyridoxamine-pyruvate aminotransferase (PPAT, EC2.6.1.30)2
is a pyridoxal 5-phosphate (PLP)-independent aminotrans-
ferase that catalyzes the transfer of an amino group between
pyridoxamine (PM) and pyruvate in the forward reaction and
between pyridoxal (PL) and L-alanine in the reverse reaction.
PPAT is involved in a degradation pathway for PM, one of six
natural vitamin B6 compounds (1). It has been purified from
Pseudomonas sp. and characterized (2). Many biochemical
studies have been performed on it (3–12), because its reaction
serves as a model for a half-reaction in the overall transamina-
tion reaction catalyzed by general PLP-dependent aminotrans-
ferases. Recently, we first identified the gene encoding PPAT in
a nitrogen-fixing symbiotic bacterium, Mesorhizobium loti
MAFF303099, characterizedwith the recombinant PPATover-
expressed in Escherichia coli cells (13), and found that it
belonged to the class V aminotransferases of fold type I of PLP-
dependent enzymes (14), although it does not use PLP as a
coenzyme.
The recombinant PPAT bound the substrate PL at Lys-197
through a Schiff base, like general aminotransferases, forming
an internal aldimine between PLP and an active site lysine res-
idue, and the Schiff base formationwas partially rate-determin-
ing in the reverse reaction. Sequence alignment of PPAT with
other class V aminotransferases showed that the amino acid
residues that have been shown to interact with PLP, based on
the crystallography of E. coli phosphoserine aminotransferase
(15) and human alanine-glyoxylate aminotransferase (AGAT;
Ref. 16), were conserved in PPAT, and it was suggested that PL
is held through interaction with these amino acid residues in
the active site of PPAT (13). The predicted active site structure
of PPAT suggested that PLP cannot bind to the enzyme because
the bulky side chain of an amino acid residue located in the
phosphate-binding space in PLP-dependent aminotransferases
prevents the approach of PLP to the active site of PPAT (13).
One of the aims of this study was to determine the amino acid
residue preventing the binding of PLP, and the extent to which
PPAT can be converted to PMP-pyruvate (PLP-L-alanine) ami-
notransferase through mutation of a relevant residue.
A further aim of this study was to propose a reaction mech-
anism for PPAT based on the structures of PPAT bound to PL,
PM, and pyridoxyl-L-alanine (PLA) and on the profile of aligned
sequences of the class V aminotransferases and kinetic results
described previously (13). To assess the contribution of Arg-
336 to the substrate specificity of PPAT,we produced the PPAT
R336A mutant and analyzed its kinetic properties.
EXPERIMENTAL PROCEDURES
Overexpression, Purification, and Enzyme and Protein Assays—
PPAT from M. loti MAFF303099 was overexpressed in E. coli
cells and purified as described previously (13). The PPAT activ-
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ity (by the phenylhydrazine method and the spectrophotomet-
ric method) and protein concentration (from the molecular
absorption coefficient) were determined as described previ-
ously (13). PMP-pyruvate aminotransferase activity was
assayed by the phenylhydrazine method as follows. The reac-
tionmixture (0.4ml) consisted of 0.1 M borate-KOH (pH 9.0), 5
mM sodiumpyruvate, 0–5mMPMP, and the enzyme. The reac-
tion was performed at 30 °C for 15–30 min and stopped by the
addition of 66 l of 9 M sulfuric acid. Kinetic parameters were
determined using curve-fitting software (KaleidaGraph) as
described previously (13).
Site-directed Mutagenesis of PPAT—Genes encoding E68A,
E68G, and R336A mutant PPATs were prepared by essentially
the samemethod as that described previously (13). The primers
used were: for E68A, 5-TGCATGGCGCGCCGGTGC-3 and
5-GCACCGGCGCGCCATGCA-3; for E68G, 5-TGCAT-
GGCGGGCCGGTGC-3 and 5-GCACCGGCCCGCCAT-
GCA-3; and for R336A, 5-CGTCGGGGGCGGGCGAGA-3
and 5-TCTCGCCCGCCCCCGACG-3. The underlining
indicates mismatched sites. The expressed mutant enzymes
were purified by essentially the same method as that used for
the wild-type enzyme (13).
Crystallization, Substrate Soaking, and X-ray Data
Collection—PPAT was crystallized by the sitting drop vapor
diffusion method. The volume of the reservoir solution (50 mM
HEPES-KOH, pH 8.0, 2 M ammonium sulfate) was 100 l, and
the drop volume was 5l, comprising 2l of a protein solution
(11.6 mg/ml in 10 mM HEPES-KOH, pH 8.0, 1 mM EDTA) and
3 l of the reservoir solution. Single crystals appeared within 1
month at 4 °C. Crystals of PM, PL, or PLA-bound forms of
PPAT were prepared by soaking crystals in the reservoir solu-
tion containing 10 mM PM, 10 mM PL, or 5 mM PLA, respec-
tively, for 30 min at 25 °C. PLA was synthesized from PL and
L-alanine as described previously (17). All of the crystals were
frozen in a cold nitrogen-gas steam after short soaking in the
reservoir solution containing 30% (v/v) glycerol. X-ray diffrac-
tion data sets were collected at the BL38B1 station of SPring-8
(Hyogo, Japan) at 173 °C, using an x-ray beam with a wave-
length of 1.0 Å and a Rigaku R-AXIS V imaging plate detector.
The crystal belongs to space group P43212 with cell dimensions
of a b 68.545 and c 311.625Å. Twomolecules/asymmet-
ric unit were estimated assumingVsol 51%.All of the raw data
were processed and scaled using the program suite HKL2000
(18). The parameters of the crystals and data collection are
listed in Table 1.
Structure Determination and Refinement—The structure of
the free form of PPAT at 2.0 Å was at first determined by the
molecular replacement method, using the structure of AGAT
(Ref. 19; Protein Data Bank code 1VJO) as a search model with
CNS (20). After rotational and translational searches and refine-
ments with simulated annealing, the initial model was built using
TURBO-FRODO (AFMB-CNRS, Marseille, France). It was then
refined further with the simulated annealing, individual B factor
refinement, and energy minimization protocols in the program
CNS. The noncrystallographic symmetry restraint was incor-
porated through the refinement, and it was removed in the final
refinement. The root mean square deviation (RMSD) values of
two subunits in the assymetric units are less than 0.4 Å (Table
1). Water molecules exhibiting more than 1  in the 2Fo  Fc
map and more than 3  in the Fo Fc map were then added to
TABLE 1
Data collection and refinement statistics
Crystal PPAT PPAT-PM PPAT-PL PPAT-PLA
Data collection
X-ray source SPring8 (BL38B1) SPring8 (BL38B1) SPring8 (BL38B1) SPring8 (BL38B1)
Wavelength (Å) 1.0000 1.0000 1.0000 1.0000
Space group P43212 P43212 P43212 P43212
a b, c (Å) 68.545, 311.635 68.628, 312.191 68.732, 311.500 68.720, 311.942
Resolution (Å)a 50.00-1.90 (1.97-1.90) 50.00-1.70 (1.76-1.70) 50.00-1.60 (1.66-1.60) 50.00-1.94 (2.01-1.94)
Total number of reflections 294615 474303 737616 528717
No. of unique reflectionsa 58804 (5701) 82435 (7561) 100019 (9737) 56030 (5397)
Rmergea 0.084 (0.379) 0.039 (0.113) 0.084 (0.386) 0.071 (0.270)
Redundancya 5.0 (5.6) 5.8 (3.0) 7.4 (7.4) 9.4 (9.7)
Completenessa 97.8 (97.2) 98.4 (91.9) 99.9 (99.9) 98.6 (97.0)
Net I over average sigma (I) 10.6 24.4 9.9 13.9
Refinement statistics
Resolution (Å)a 15.00-2.00 (2.05-2.00) 14.94-1.70 (1.74-1.70) 14.84-1.70 (1.74-1.70) 14.92-1.94 (1.99-1.94)
Rworka 0.156 (0.180) 0.156 (0.168) 0.154 (0.174) 0.145 (0.157)
Rfreea 0.206 (0.245) 0.186 (0.223) 0.181 (0.231) 0.184 (0.222)
No. of reflectionsa 47892 (3441) 78010 (5183) 79313 (5695) 52891 (3677)
No. of reflections (Rfree)a 2551 (196) 4094 (255) 4123 (294) 2827 (208)
No. of protein residues 784 784 784 784
No. of substrate/substrate analog molecules 0 2 PM 2 PL 2 PLA
No. of glycerol molecules 4 4 7 10
No. of sulfate ions 6 5 7 8
No. of chloride ions 0 0 0 2
No. of solvent molecules (water) 550 753 778 614
RMSD bond lengths (Å) 0.015 0.010 0.010 0.013
RMSD bond angles (°) 1.440 1.248 1.243 1.342
Average B overall (Å2) 18.596 14.852 12.800 18.258
Subunit RMSD (Å) 0.39 0.37 0.35 0.34
Ramachandran analysis (% of residues)
Most favored 93.3 93.4 93.9 93.9
Additional allowed 6.4 6.2 5.9 5.8
Generously allowed 0.3 0.3 0.2 0.3
Disallowed 0 0 0 0
a Statistics for the highest resolution shell are given in parentheses.
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the model. The structures of the PM-, PL-, and PLA-bound
forms of PPAT were built using COOT (21) and refined with
REFMAC5 (22) in the ccp4 suite (23). The topology and param-
eter files for PM and PL were obtained from the HIC-UP server
(24), and those for PLA were generated using the PRODRG
server (25). The stereo quality of the model was assessed using
PROCHECK (26). The statistics of the data collection and the
refinement are listed in Table 1.
The structural superimpositioning was performed using the
FATCAT server (27). All of themolecular graphics figures were
prepared using the program PyMOL (DeLano Scientific;
pymol.sourceforge.net/). The accessible surface area was calcu-
lated with Protein-Protein Interaction Server version 1.5 (28).
Modeling of the External Aldimine of PL with L-Alanine in
PPAT—For modeling of the external aldimine of PL with L-al-
anine in the active site of PPAT, the crystal structure of PPAT in
a complex with PLA was used as the starting structure. Molec-
ular mechanic calculations were performed using MOE (ver-
sion 2006.08; Chemical ComputingGroup Inc.,Montre´al, Can-
ada). Protons were generated on the entire structure including
the water molecules. The bond between C-4 and N of the ala-
nine moiety of PLA was changed to a double bond, the N atom
of the generated imine bond being
protonated. TheO-3 andN-1 of PL
were unprotonated and protonated,
respectively. The chloride ion was
removed, and the side chain of Asn-
196 was rotated around 1 by 135 °
to yield a conformation similar to
that of the side chain of Asn-196 in
other PPAT crystal structures (free
enzyme, and the enzymes in com-
plexes with PL and PM). Energy
minimization was carried out using
MMFF94s parameters with all of
the atoms fixed except for those of
PLA and the residue interacting
with PLA, i.e. Lys-197, Arg-345,
Tyr-95, Thr-146, Glu-68, Arg-336,
and water molecules within 10 Å
from PLA. Polar protons are also
allowed to move.
Protein Data Bank Deposition—
The coordinate and structure fac-
tors for the free enzyme, and com-
plexes with PL, PM, and PLA have
been deposited in the RCSB Pro-
tein Data Bank under accession
codes 2Z9U, 2Z9V, 2Z9W, and
2Z9X, respectively.
RESULTS ANDDISCUSSION
Structure Determination of PPAT—
The crystal structure of PPAT from
M. loti has been solved by means of
molecular replacement and was
refined toanR factorof 15.6% (Rfree
20.6%) at 2.0 Å resolution. In addi-
tion, the structures of PPAT in complexes with PM, PL, and
PLA have been refined to R factors of 15.6, 15.4, and 14.5%
(Rfree 18.6, 18.1, and 18.4%) at 1.7, 1.7, and 2.0 Å resolution,
respectively. The final electron density maps allowed the posi-
tioning of all residues except for the first N-terminal residue
(Met-1). Ramachandran plot analyses with PROCHECK (26)
showed that 93–94% of the residues are in the most favored
regions, and6% of those lie in additional allowed regions for
all of the forms (Table 1).
Overall Structure of PPAT—There are two molecules (sub-
units)/asymmetric unit of PPAT (Fig. 1A). Each PPAT subunit
consists of a large N-terminal domain (22–267), and a smaller
C-terminal domain (2–21 or 268–393) (Fig. 1, A and B). The
N-terminal domain has the three-layer // sandwich archi-
tecture described in the CATH classification (29), and consists
of eight -helices (1–8) and seven -sheets (1–7), which
have a 11–27–16–15–14–12–13 arrange-
ment (Fig. 1B). This domain is characteristic of PLP-dependent
fold-type I aminotransferases (30). The C-terminal domain has
an / complex architecture and consists of an N-terminal
strand, four -helices (9–12), and three-stranded anti-par-
allel-sheets (8–10). The topology of the PPAT subunit was
FIGURE 1. Crystal structure of PPAT. A, ribbon diagram of the PPAT asymmetric dimer in a complex with PL.
The N-terminal domain and C-terminal domain of subunit A are shown in green and yellow, whereas those of
subunit B are shown in cyan and purple, respectively. B, stereo ribbon diagram of the PPAT monomer in a
complex with PL. The N-terminal domain and C-terminal domain are shown in green and yellow, respectively.
Lys-197-PL is shown as a blue-colored stick model. Secondary structure elements, the N and C termini, and
residues 22 and 267 are labeled. C, ribbon diagram of the PPAT tetramer in a complex with PL. The two
monomers in the asymmetric unit are depicted in green and cyan, respectively. Two dimers, related through a
crystallographic 2-fold axis, form a PPAT tetramer. PL is shown as a red-colored stick model. The figures were
drawn with PyMOL.
Structure of Pyridoxamine-Pyruvate Aminotransferase
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basically similar to those of class V aminotransferases such as
the Saccharomyces cerevisiae and Nostoc sp. AGATs (19, 31),
with the exception of having an extra -helix (12) at the C
terminus. The mode of dimer formation by PPAT was slightly
different from that in the case of AGATs because PPAT does
not have the longer N-terminal strand that is found in the sub-
units of AGATs and stabilizes the formation of their dimers.
Two dimers, related through a crystallographic 2-fold axis,
form a PPAT tetramer, i.e. a dimer of dimers (Fig. 1C). This is in
good agreement with the finding that native PPAT is a tetramer
in solution when its molecular weight was determined by size
exclusion chromatography (13). Two subunits (A and B) in one
asymmetric unit associate with those (A and B) in the other
asymmetric one. Subunit A exhibits interface accessible surface
areas of2,000, 200, and 1,200 Å2 as to subunits B, A, and B,
respectively. Thus, subunits A and B are tightly associated
through an extensive contact and exhibit 14 hydrogen bonds
interactions and 240 hydrophobic interactions. The dimers
(AB and AB) associate through interactions between the
C-terminal domains of subunits A (B) and B (A) and those
between the C-terminal domain of subunit A (B) and the
N-terminal strand (2–31 residues) of subunit B (A). Thus,
there are 20 hydrogen bonds and 240 hydrophobic interac-
tions between the dimers.
A structural homology search using MATRAS version 1.2
(32) showed that the tertiary structure of the M. loti PPAT
subunit is similar to those of S. cerevisiae AGAT (Ref. 31, Pro-
tein Data Bank code 2BKW, Z score 51.84, sequence identity
24%),Nostoc sp. AGAT (Ref. 19, Protein Data Bank code 1VJO,
Z 51.50, 26%), Thermus thermophilus aspartate aminotrans-
ferase (Ref. 33, Protein Data Bank code 1IUG, Z 48.31, 23%),
Salmonella typhimurium 2-aminoethylphosphonate-pyruvate
aminotransferase (Ref. 34, Protein Data Bank code 1M32, Z
42.43, 25%), and Bacillus alcalophilus phosphoserine amino-
transferase (Ref. 35, Protein Data Bank code 1W23, Z 34.69,
16%), all of which are class V aminotransferases of fold-type I of
PLP-dependent enzymes. RMSD for PPAT, when superim-
posed with the S. cerevisiae andNostoc sp. AGATs, were 1.85 Å
(for 358 C atoms) and 1.92 Å (for 362 C atoms), respectively.
Active Site of PPAT and Substrate Recognition—In contrast
to general aminotransferases, the native PPAT had no coen-
zyme forms of vitamin B6, i.e. PLP or PMP (13). The residual
electron density of the free form of
PPAT determined here clearly
showed that it has no coenzyme.
Instead, one glycerol (from the cryo-
protectant solution) and one sulfate
ion (from the reservoir solution)
bound to the active site (Fig. 2) that
is situated at the interface in the
dimer (Fig. 1A). When PPAT had
been incubatedwith PL, it bound PL
through a Schiff base linkage (13).
Here, it was found that PL is bound
to the  amino group of Lys-197
through a double bond (an external
aldimine) in the active site in the
PPAT-PL complex, as shown in Fig.
2. One molecule of PL bound to both subunits in the asymmet-
ric unit. PL is stacked between Tyr-95 and Val-173 through
hydrophobic interactions, and the phenol ring of Tyr-95 is sit-
uated at the re face of the pyridine ring of PL. The side chain of
Thr-146 is hydrogen-bonded to the O-3 atom of PL, and this
bond stabilizes its deprotonated state. The side chain of Thr-
146 is kept in place through hydrogen bonding to O of Ser-
174. The negative charge on the O-3 atom of PL stabilizes the
protonated form of the imine nitrogen of the external aldimine
because they can form an intramolecular hydrogen bond (36).
Actually, the PL-Lys-197 Schiff base is protonated in a solution
of pH 8.0, as determined on spectrophotometric analysis (13).
The torsion angle of the C-3—C-4–C-4–N-4 bond of the PL-
lysine-197 Schiff base is 23°, and the Schiff base is roughly
coplanar with the pyridine ring. The protonated Schiff base in
E. coli aspartate aminotransferase is also nearly coplanar with
the pyridine ring of PLP (36, 37). The side chain of Asp-171
forms a charged hydrogen bond with the protonated N-1 atom
of PL, stabilizing the protonated N-1 to strengthen the elec-
tron-withdrawing capacity of PL (38). The side chain of Glu-68
is hydrogen-bonded to O-5 of PL. PL exhibits van der Waals’
interactions with Pro-69, Cys-142, His-144, and Ser-174. The
sulfate ion from the reservoir solution lies near the PL at the
active site and forms charged hydrogen bonds with N1 and
N2 of Arg-345. This residue corresponds to the arginine
involved in the recognition of the substrate -carboxylate in
class V aminotransferases. The sulfate is also hydrogen-bonded
to O of Tyr-95 and N1 of Arg-336.
One molecule of PM is bound to both subunits in the asym-
metric unit. In the PPAT-PM complex, PM is anchored to the
same residues as those used for anchoring PL throughhydrogen
bonds and hydrophobic and van der Waals’ interactions: Glu-
68, Pro-69, Val-70, Leu-73, Tyr-95, Cys-142, His-144, Thr-146,
Asp-171, Val-173, Ser-174, and the sulfate ion (Fig. 2). In con-
trast to for the PPAT-PL complex, PM is not covalently bound
to Lys-197. Accordingly, the pyridine ring of the anchored PM
tilts in the direction of Tyr-95 by18 ° around N-1. Tyr-95 itself
also tilts in the same direction. N-4 of PM is hydrogen-bonded
to O of Tyr-95 andO-1 andO-4 of the sulfate ion. N-4 of PM
also forms an intramolecular hydrogen-bond with O-3 of the
pyridine ring. The side chain of Lys-197 is hydrogen-bonded to
O of Ala-16 and O of Gly-17 and O-1 of the sulfate ion.
FIGURE 2. Stereo stick model of the superimposed active site structure of the free form of PPAT
(magenta), and the PM-bound (white) and PL-bound (green) ones. Sulfate ions of the free form of PPAT
(magenta), and the PM-bound (white) and PL-bound (green) ones are indicated. Oxygen and nitrogen atoms
are shown in red and blue, respectively. The position of glycerol in the free form is hard to see, but it bound to
the position corresponding to C-2, C-2, and C-3 of PM (PL). The figure was drawn with PyMOL.
Structure of Pyridoxamine-Pyruvate Aminotransferase
JANUARY 11, 2008•VOLUME 283•NUMBER 2 JOURNAL OF BIOLOGICAL CHEMISTRY 1123
 at KO
CHI UNIVERSITY, on Novem
ber 8, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
The binding of PL and PM did not induce large conforma-
tional changes in the enzyme protein. The structures of the free
form and the complexes could be superimposed well with C
RMSD of0.2 Å for their all C atoms.
Binding of the Substrate Amino/Keto Acid—To identify
the residues of PPAT involved in amino/keto acid binding, we
determined the three-dimensional crystal structure of the
enzyme in a complex with PLA, a bisubstrate analog. In the
PPAT-PLA complex, the pyridoxyl moiety of PLA is anchored
to the same residues as those used for anchoring PL or PM
through hydrogen bonds and hydrophobic and van der Waals’
interactions. The alanine moiety is recognized by Gly-17, Tyr-
95, Thr-146, Pro-147, Thr-248*, Arg-336, and Arg-345 (the
asterisk indicates a residue of another subunit) (Fig. 3). Arg-345
particularly forms charged hydrogen bonds with the -carbox-
ylate group of the alanine moiety, with distances of 2.7 and 2.8
Å. The side chain of Arg-345 is kept in place by a hydrogen-
bonding network involving O of Thr-146 and O of Ser-334.
Upon PLA binding, a -turn (Ala-16–Gly-17–Pro-18–Val-19)
containing the cis peptide bond between Gly-17 and Pro-18 on
the N-terminal strand approaches the active site by 1.7 Å at the
Gly-17 C position. The approach
of this -turn plugs the enzyme
active site and thus shields PLA
from the solvent environment. In
the PPAT-PLA complex, the region
of the twice repeated -turns (Gly-
194–Gly-204) between6 and7 in
the active site also moved; the main
change was movement of the side
chains of Asn-196 and Lys-197. In
connection with this conforma-
tional change, one chloride ion was
found in the space surrounded by
Asn-196, Lys-197, and Glu-68. This
chloride ion forms charged hydro-
gen bonds with N of Asn-196 and
N	 of Lys-197. In the free form and
PPAT-PM complex, a sulfate ion
forms charged hydrogen bondswith
Arg-345, and the protonated side
chain N	 of Lys-197 is attracted to
the sulfate ion because of a strong
negative charge. On the other hand,
in the PPAT-PLA complex, this sul-
fate ion is absent from the model
because the alanine moiety of PLA
forms a hydrogen bond/salt bridge
withArg-345. The side chain of Lys-
197 cannot interact with this sulfate
in thismodel. Instead,N	 of Lys-197
is hydrogen-bonded to the O-5
atom of PLA because its pyridine
ring is shifted up, as described
below. The presence of the side
chain of Lys-197 at this position dis-
places the side chain of Asn-196,
with rotation around 1 by 135°. As
a result, a chloride ion can be incorporated into the space pre-
viously occupied by the side chain of Asn-196.
In thePPAT-PLAcomplex, thedistancebetweenN	ofLys-197
and C of PLA alanine is 5.3 Å. This distance is too great if we
consider that thePPAT-PLAcomplexrepresents theexternalaldi-
mine complex of PPAT with alanine and that Lys-197 is the base
catalyst for theprototropic shift.Moreover, there areno candidate
residues that can act as the base catalyst around the PLAC atom.
This suggested that the position and conformation of PLA is not
an appropriate model for the external aldimine, In fact, the
absenceof thedoublebondofC-4–C-4and the sp3natureofPLA
alanineNallows rotation aroundC-4–C-4 and the formationof a
hydrogen bond betweenPLAalanineNand the hydroxyl group of
Tyr-95, both of which are not anticipated to occur in the true
external aldimine between PL and alanine.
External Aldimine Model and Catalysis—To estimate the
true external aldimine structure, we have calculated the energy-
minimized structure of the PL-alanine Schiff base in the active
site of PPATbased on the PPAT-PLA complex structure. In the
external aldimine model (Fig. 4), the pyridine ring is shifted
down compared with that of PLA. This is mainly caused by the
FIGURE 3. Stereo stickmodel of the active site structure of PPAT in a complexwith PLA. The PLAmolecule
is shown in yellow, andprotein residues and the chloride ion are in green. The hydrogenbonds are indicatedby
dotted lines. The line models are the superposed active site structures of PPAT-PM (cyan) and PPAT-PL
(magenta) complexes. The figure was drawn with PyMOL.
FIGURE 4.Deduced external aldiminemodel. The structure of PPAT in a complex with a Schiff base (external
aldimine) between PL and L-alanine was deduced with the MOE program. The PL-alanine Schiff base is shown
in yellow, andhydrogens are added to themodel. The hydrogenbonds involved in the substrate-carboxylate
group binding are indicated by dotted lines. The line models are the superposed active site structure of the
PPAT-PM complex (cyan). The figure was drawn with PyMOL.
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opening of the angle C-4–C-4–N and C-4–N-C, because
C-4 and alanine N of the external aldimine exhibit sp2 hybrid-
ization, compared with those of PLA that exhibit sp3 hybridiza-
tion. Accordingly, the side chain of Lys-197 does not form a
hydrogen bondwithO-5 of PL. The imineN atomof the exter-
nal aldimine forms an intramolecular hydrogen bond with
O-3 of PL, the hydrogen bond with O of Tyr-95 being lost.
As a result, the distance between the Lys-197 side chain N
atom and the C atom of the external aldimine alanine is 3.7
Å, showing that Lys-197 can be the base catalyst for the
prototropic shift. Thus, the PPAT reaction can be catalyzed
in the same way as those of other PLP-dependent amino-
transferases by the catalytic base, Lys-197, with the catalytic
assistance of Asp-171 and Thr-146.
In the external aldimine model, the alanine -carboxylate is
hydrogen-bonded to two arginine residues (Arg-345 and Arg-
336). In other class V aminotransferases, the -carboxylate is
attached to an arginine residue corresponding to PPAT Arg-
345 through a hydrogen bond and salt bridge (15, 39). The side
chain of Arg-336 is more flexible in all forms of PPAT and lies
near the alanine moiety of PLA bound to PPAT. To determine
the contribution of this residue to catalysis, a mutant enzyme
(R336A) in which Arg-336 was replaced with alanine was char-
acterized. The kinetic parameters of the wild-type and R336A
PPATs are shown inTable 2. The affinity for pyruvate of R336A
was remarkably decreased by 20-fold compared with that of
the wild-type PPAT, whereas the affinity for PMwas decreased
only by2-fold. Thus, Arg-336 is considered to be involved in
the recognition and binding of amino/keto acid substrates in
PPAT, probably by forming a hydrogen bondwith the substrate
-carboxylate group.
Comparison with PLP-dependent Aminotransferases with
Regard to PLP Recognition—General aminotransferases have
PLP as a coenzyme. In contrast, PPATcould not bind PLP/PMP
and did not catalyze the PMP-pyruvate aminotransferase reac-
tion (13). To determine why PPAT cannot bind PLP/PMP, the
active site structure of the PPAT-PL complex was superim-
posed on that of Nostoc sp. AGAT (Fig. 5). In the active site of
AGAT, the phosphate group of the coenzyme is hydrogen-
bonded toO of Thr-81, N of Gly-82, N andO of Thr-83, andN
of Gln-208. Glu-68, Pro-69, Val-70, and Gln-196, respectively,
occupy the corresponding positions in the active site of PPAT.
Pro-69 cannot form a hydrogen bondwith the phosphate group
because the lone pair electrons of its main chain amide N resi-
due are occupied by the side chain C atom. Furthermore, the
twoO atoms (O1 andO2) of Glu-68 are hydrogen-bonded to
the O-5 atom of PL, the distances between them being 2.8 and
3.2 Å. Thus, there is no space for the phosphate group of PLP in
the active site of PPATbecause of the presence of the side chain
of Glu-68. To determine the role of Glu-68 in substrate recog-
nition, it was replaced with alanine (E68A) or glycine (E68G)
with smaller side chains. As expected, the E68A and E68G
PPATs showed low but detectable PMP-pyruvate aminotrans-
ferase activity (Table 2). These mutants could also bind PLP
(measured spectrophotometrically; data not shown). The
results showed that Glu-68 interferes with the binding of PLP/
PMP phosphate and makes PPAT specific to PL/PM. On the
other hand, the E68A and E68G PPATs showed the remarkably
decreased activity toward PM compared with that of the wild-
type PPAT (Table 2). This suggested that Glu-68 is an impor-
tant residue in the catalytic reaction of PPAT.
Reaction Mechanism of PPAT—The arrangement of amino
acid residues and their interactions with substrates in the active
site of PPAT described above suggest that although PPAT cat-
alyzes transamination between PL/PM and amino/keto acids,
the transamination reaction proceeds via essentially the same
mechanism as that in the case of general PLP-dependent ami-
notransferases. Lys-197 is the base catalyst for the prototropic
shift. Asp-171 and Thr-146 are considered to adjust the elec-
tronic status as well as to maintain the conformation and ori-
entation of the Schiff base. Arg-336 and Arg-345 are used for
the amino/keto acid recognition.
Scheme 1 shows a proposed reac-
tion mechanism for PPAT. PPAT
first binds PM and then forms a
Michaelis complex with the incom-
ing pyruvate. The ketimine is
formed through nucleophilic attack
of the N-4 atom of PM on the
-carbon atom of pyruvate, which
is followed by the release of a water
molecule. The stereospecific 1,3-
prototropic shift between the keti-
mine and external aldimine via the
quinonoid intermediate is accom-
plished through general base cataly-
FIGURE 5. Stereo view of the superimposed active site structures of the PPAT-PL complex (green) and
Nostoc sp. AGAT (white).Note the steric clashing of the phosphate group of PLP of AGAT with the side chain
of Glu-68 of PPAT. The figure was drawn with PyMOL.
TABLE 2
Kinetic parameters of the wild-type andmutated (R336A, E68A, and
E68G) enzymes
Substrate kcat Km kcat/Km
s1 mM s1 M 1
Wild type PMa 28 0.5 0.044 0.004 640,000
Pyruvatea 0.34 0.02 85,000
PMPb NDc NDc NDc
R336A PMa 28 2.0 0.10 0.02 270,000
Pyruvatea 6.9 0.85 4,000
E68A PMPb 0.22 0.03 3.4 0.24 65
PMb 0.78 0.03 1.3 0.13 590
E68G PMPb 0.062d NDc NDc
PMb 0.77 0.05 2.5 0.30 310
a The enzyme activity was determined by the spectrophotometric method.
b The enzyme activity was determined by the phenylhydrazine method.
cND, not detectable.
d The enzyme activity was determined with 5 mM PMP.
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sis by Lys-197. PL and L-alanine are formed from the external
aldimine and released from PPAT. There are two possible
pathways for the dissociation of the external aldimine into
PL and L-alanine, that is, the external aldimine may be
hydrolyzed to directly form PL and L-alanine, or the external
aldimine first undergoes transaldimination to form L-alanine,
and a Schiff base between PL and Lys-197, and then the latter is
hydrolyzed to yield the free enzyme and PL. In either case, the
hydrolysis of the Schiff base is thought to be partially rate-de-
termining, as anticipated on kinetic consideration of theKd and
Km values of PM and PL (13). Crystallographic and spectropho-
tometric experiments showed that the internal Schiff base
between Lys-197 and PL really exists (13). However, this does
not indicate that the internal Schiff base is the necessary inter-
mediate in the PPAT reaction. The importance of this species in
catalysis depends on the compara-
tive formation/hydrolysis rates of
the internal and external Schiff
bases. This is a problem to be solved
in the future.
In contrast to coenzymes PLP
and PMP in general aminotrans-
ferases, substrates PL and PM
should dissociate from PPAT for
the next cycle of the reaction.
Because PL and PM do not have a
phosphate group,which is anchored
in the active site through several
hydrogen bonds in general amino-
transferases, the strength of their
interaction with PPAT should be
much lower (approximately half,
based on the number of hydrogen
bonds), and thus they can easily dis-
sociate from PPAT. Indeed, the
E. coli aspartate aminotransferase
Y70F mutant, in which Tyr-70
involved in the formation of a
hydrogen bond with the phosphate
of PLP is replaced by phenylalanine,
showed lower affinity for PLP and
released it more readily than the wild-type enzyme (40). Fur-
thermore, PPAT has a side chain arrangement of residues
around the active site that allows easy dissociation of substrates.
Fig. 6 shows the active site structures of PPAT and Nostoc sp.
AGAT. The volumes of their active sites are almost the same,
and their topological characters are the same. However, many
residues with bulky side chains, such as Tyr-107, Arg-111, Trp-
240*, andTyr-257*, exist in the active site of theAGATand thus
shield the active site (* means a residue of another subunit). In
contrast, the corresponding residues in PPAT are Val-94, Gly-
98, Ala-227*, and Pro-244*, respectively. These residues have
short side chains and thus would not interfere with PM and PL
entering and exiting the active site of PPAT.
Here, we have determined for the first time the crystal struc-
ture of a PLP-independent aminotransferase and proposed its
reaction mechanism. PM binds to the active site of PPAT and
forms a tertiary complex together with pyruvate and is changed
to PL with the assistance of amino acid residues located in the
active site. From the evolutional aspects, it is quite interesting
to expect the presence of other types of enzymes that use PL as
one substrate and racemize or decarboxylate another substrate
such as an amino acid.
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